Deep Brain Stimulation Clinical Trials

Clinical trials related to Deep Brain Stimulation Procedure

Effect of Physical Activity on the Course of Parkinson's Disease in Patients With Bilateral DBS-STN Stimulation - a Randomized Controlled Trial.

Status: Recruiting
Location: See location...
Intervention Type: Procedure, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Parkinson's disease is a common, progressive neurodegenerative disorder. The degeneration of dopaminergic neurons is associated with characteristic clinical symptoms such as tremor, rigidity, slowness of movement (bradykinesia) and postural instability. Subthalamic nucleus deep brain stimulation (DBS-STN) is a recognized and widely used method of treating advanced stages of Parkinson's disease. It improves clinical symptoms such as tremor, rigidity and slowness of movement (bradykinesia). This method has limited application for late motor and non-motor symptoms such as: akinesia, postural instability, gait, including the phenomenon of freezing, recurrent falls, balance and dysarthria. These symptoms reduce the quality of life of patients and make them dependent on their caregivers. There is a clear need to develop additional forms of therapy that complement deep brain stimulation in controlling late motor and non-motor symptoms. Physical activity is a commonly used and recommended form of therapy for patients with Parkinson's disease and a complement to pharmacological therapy, improving gait, balance and quality of life. However, there are no clear recommendations including patients after implantation of DBS-STN stimulators to the group undergoing physiotherapy. To this day, only one clinical trial has been registered assessing the effect of physiotherapy on balance and gait in patients with DBS-STN.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 70
Healthy Volunteers: f
View:

• Patients diagnosed with idiopathic Parkinson's disease (ICD-10:G20).

• Patients qualified for advanced therapies using DBS-STN.

• Grade II-IV on the Hoehn \& Yahr scale.

• Age 50-70.

• Consent to participate in the study.

Locations
Other Locations
Poland
Department of Neurology, Faculty of Health Sciences, Bródnowski Mazovian Hospital
RECRUITING
Warsaw
Contact Information
Primary
Marta M Betka, PhD student
marta.maria.betka@gmail.com
48798789277
Time Frame
Start Date: 2024-09-05
Estimated Completion Date: 2028-09-05
Participants
Target number of participants: 102
Treatments
Experimental: Research group
Sham_comparator: Control group
Sponsors
Leads: Medical University of Warsaw

This content was sourced from clinicaltrials.gov